MTPConnect and Wholesale Investor are collaborating to expand the ecosystem’s access to this essential investor class and enhance companies’ investor readiness with a dedicated capital engagement program.
The MTPConnect Investor Ready Program aims to enhance life science companies’ readiness for investment and connecting companies directly with Wholesale Investor’s network of over 45,000 investors.
Our 2025-2026 curated program included a package of activities to assist participating companies with their capital raising requirements. It culminated in showcasing participating companies at the Emergence 2026 Conference in February 2026, in Sydney. There was a fee to participate.
The program also included Investor Education designed for investors, to demystify investing in opportunities/companies in the life sciences sector.
For queries, please reach out to Wholesale Investor’s Steve Torso or contact the MTPConnect team.
Wholesale Investor Co-Founder and Managing Director Steve Torso is behind one of the largest capital raising platforms in Australia, and he joins the podcast to talk about how the MTPConnect Investor Ready program can help life science companies develop an investor network, build a skill base in investor communications and avoid some of the pitfalls when engaging with investors.
He covers what to expect at our upcoming inaugural Life Science Investor Day as part of Wholesale Investor’s Emergence 2026 conference, which will bring together ASX-listed innovators, breakthrough private companies, and global investors driving the future of health, diagnostics, and therapeutics.
Listen to episode 204, Raising Capital with MTPConnect and Wholesale InvestorWatch the on-demand video of the presentations, keynotes and panel discussions from the sold-out Life Sciences Investor Day 2026 – featuring 30+ companies from the life sciences sector.
Why is 3% of global research coming from just 0.3% of the population?
In this exclusive panel hosted by MTPConnect COO Lisa Dube, top investors and CEOs reveal the “sliding door” moments that define billion-dollar companies. Featuring Proto Axiom’s Anthony Liveris, Artesian’s Stephanie Morris, 4D Medical’s Dr. Andreas Fouras, and Dimerix’s Robert Shepherd, we dive into the systemic reasons Australian firms scale offshore and how to fix it.
Find out more about the program from our Information Session: Raising Capital in 2026, held in October 2025.
Next week we bring you the inaugural Life Sciences Investor Day at Emergence, in partnership with Wholesale Investor featuring more than 30 life sciences companies
Read More
We are partnering with Wholesale Investor to host the inaugural Life Sciences Investor Day at Emergence, a premier investment conference in February that will showcase 25 life science companies!
Read More
MTPConnect, Australia’s Life Sciences Innovation Accelerator and Wholesale Investor, a leading private capital marketplace today announced a landmark strategic partnership …
Read More
